S Wassenberg

618 total citations
8 papers, 408 citations indexed

About

S Wassenberg is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, S Wassenberg has authored 8 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in S Wassenberg's work include Rheumatoid Arthritis Research and Therapies (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). S Wassenberg is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). S Wassenberg collaborates with scholars based in Germany, Netherlands and Spain. S Wassenberg's co-authors include G. Herborn, R. Rau, Gerold Stucki, R. Rau, Piet L. C. M. van Riel, Matthias Schneider, P. Herzer, Thasia Woodworth, S. Kary and Joachim Listing and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and PubMed.

In The Last Decade

S Wassenberg

8 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Wassenberg Germany 6 290 126 105 96 39 8 408
Margaret Michalska United States 9 193 0.7× 82 0.7× 89 0.8× 28 0.3× 31 0.8× 22 291
С. И. Глухова Russia 8 205 0.7× 54 0.4× 106 1.0× 39 0.4× 38 1.0× 149 316
Alessandra Zanola Italy 9 174 0.6× 64 0.5× 101 1.0× 88 0.9× 82 2.1× 11 365
Cathrin Nikolaisen Norway 9 241 0.8× 50 0.4× 133 1.3× 25 0.3× 37 0.9× 9 332
Michael Batley United Kingdom 4 317 1.1× 71 0.6× 52 0.5× 27 0.3× 60 1.5× 6 423
K. Veres Hungary 7 214 0.7× 64 0.5× 170 1.6× 40 0.4× 28 0.7× 11 333
Sahena Haque United Kingdom 11 219 0.8× 33 0.3× 171 1.6× 47 0.5× 55 1.4× 19 346
Anthony J. Sliwinski United States 9 138 0.5× 57 0.5× 101 1.0× 24 0.3× 32 0.8× 18 294
Marta Novella-Navarro Spain 9 172 0.6× 41 0.3× 49 0.5× 26 0.3× 38 1.0× 41 243
Hee Jung Ryu South Korea 11 191 0.7× 41 0.3× 92 0.9× 48 0.5× 19 0.5× 22 320

Countries citing papers authored by S Wassenberg

Since Specialization
Citations

This map shows the geographic impact of S Wassenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Wassenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Wassenberg more than expected).

Fields of papers citing papers by S Wassenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Wassenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Wassenberg. The network helps show where S Wassenberg may publish in the future.

Co-authorship network of co-authors of S Wassenberg

This figure shows the co-authorship network connecting the top 25 collaborators of S Wassenberg. A scholar is included among the top collaborators of S Wassenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Wassenberg. S Wassenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Balsa, Alejandro, S Wassenberg, Anne Tournadre, et al.. (2022). POS0518 EFFECT OF FILGOTINIB (FIL) ON BODY WEIGHT (BW) AND BODY MASS INDEX (BMI) AND EFFECT OF BASELINE BMI ON THE EFFICACY AND SAFETY OF FIL IN RHEUMATOID ARTHRITIS (RA). Annals of the Rheumatic Diseases. 81. 516–517. 2 indexed citations
3.
Alten, Rieke, Hermann Gram, Leo A. B. Joosten, et al.. (2008). The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Research & Therapy. 10(3). R67–R67. 136 indexed citations
4.
Zink, A., Joachim Listing, S. Kary, et al.. (2005). Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Annals of the Rheumatic Diseases. 64(9). 1274–1279. 126 indexed citations
5.
Herborn, G., et al.. (2005). Healing of erosive changes in rheumatoid arthritis.. PubMed. 22(5 Suppl 35). S44–9. 12 indexed citations
6.
Breedveld, FC, C.F. Allaart, R. Rau, et al.. (2001). OP0062 The fully human anti-tnf antibody adalimumab (d2e7) in combination with methotrexate (mtx) in the treatment of active rheumatoid arthritis: results of a 2-year study. Annals of the Rheumatic Diseases. 60. A479–A479. 8 indexed citations
7.
Rau, R., et al.. (1998). A new method of scoring radiographic change in rheumatoid arthritis.. PubMed. 25(11). 2094–107. 116 indexed citations
8.
Wassenberg, S, et al.. (1993). Can methotrexate reduce the renal toxicity of parenteral gold?. PubMed. 20(4). 759–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026